---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-000317"
form_type: "8-K"
ticker: "XERS"
cik: "0001867096"
company_name: "Xeris Biopharma Holdings, Inc."
filed_at: "2022-01-03T23:59:59+00:00"
generated_at: "2026-06-27T21:29:40.151171+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Xeris Biopharma raises $30M in private placement with Armistice Capital

## Summary
- Gross proceeds of $30M from sale of 10.2M shares at $2.93/share (closing price Dec 31, 2021).
- Warrants to purchase up to 5.1M shares at $3.223/share, exercisable immediately for 5 years.
- Net proceeds to support operations, commercial products, clinical trials, working capital.
- Private placement expected to close Jan 3, 2022; resale registration statement to be filed.

## SEC filing metadata
- accession: 0001193125-22-000317
- form_type: 8-K
- ticker: XERS
- cik: 0001867096
- company_name: Xeris Biopharma Holdings, Inc.
- filed_at: 2022-01-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867096/000119312522000317/0001193125-22-000317-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867096/000119312522000317/d221763d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-000317
- JSON: https://secwatch.observer/filing/0001193125-22-000317.json
- Plain text: https://secwatch.observer/filing/0001193125-22-000317.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.